"FUZEON is a revolutionary therapy and for the majority of patients the significant improvements in health far outweigh the burden of the injection. It is alarming that many of these patients offered FUZEON are not accepting the offer due to the fear of injection and are missing out on the modern era of HIV therapy," comments Professor Joep Lange, President of the International AIDS Society.
Comprehensive FUZEON benefits seen by 3 months and maintained at 2 years
Dramatic FUZEON virological benefits can be seen as early as 1 week. Within just 3 months, FUZEON patients are twice as likely to achieve undetectable levels of HIV compared to those who are not taking FUZEON. Furthermore, data show these benefits are maintained at 2 years. FUZEON patients also reported approximately half the incidence of diarrhoea, a common and often debilitating side effect associated with HIV therapy.
"We urge physicians and nurses to work closely with their patients during the first 3 months of FUZEON therapy, by which time dramatic benefits should be seen and self injection should have become routine," comments Dr Mike Youle, Royal Free Hospital, London.
The pivotal role of physicians and nurses
"It is essential that, as physicians, we present FUZEON to all triple class experienced patients, balancing the remarkable improvements in viral load, CD4 count and quality of life, with the need for self-injection. Our challenge is to iden